Isabl

Isabl is a biotechnology company focused on transforming cancer diagnosis through comprehensive genomic testing. Their primary product, Isabl GxT, utilizes whole genome and transcriptome sequencing to analyze tumor biopsies. Unlike traditional panel-based diagnostic tests that examine less than 1% of the cancer genome, Isabl GxT analyzes 100% of the tumor genome, enabling the identification of clinically relevant mutations that were previously inaccessible. This approach aims to provide a more thorough understanding of cancer biology, ultimately leading to better diagnostic outcomes for patien…